日本數位療法市場報告：按應用、最終用途和地區分類（2026-2034年）

Japan Digital Therapeutics Market Report by Application (Diabetes, Obesity, CVD, CNS Disease, Respiratory Diseases, Smoking Cessation, and Others), End Use (Patients, Providers, Payers, Employers, and Others), and Region 2026-2034

出版日期: 2026年01月01日 | 出版商:

IMARC | 英文 115 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2025年，日本數位療法市場規模達3.848億美元。 IMARC Group預測，到2034年，該市場規模將達到20.192億美元，2026年至2034年的複合年成長率（CAGR）為20.23%。推動市場成長的關鍵因素包括：關節炎、心血管疾病、糖尿病和骨質疏鬆症等各種慢性疾病的日益普遍，人工智慧（AI）和機器學習（ML）技術的進步，以及明確的指導方針和框架的建立。

數位療法是基於軟體的干涉措施，旨在透過行為改變和臨床支持來改善健康結果。這包括專注於改變行為模式以應對壓力、焦慮和憂鬱症等心理健康問題的行為療法應用程式。它們還包括慢性病管理平台，這些平台透過藥物提醒、活動追蹤和個人化健康建議等功能，幫助患者監測和管理自身病情。遠端患者監護也屬於此類，它利用穿戴式裝置和感測器遠端監測患者的生命徵象和健康指標。數位療法的有效性是基於科學證據和臨床試驗，通常需要經過嚴格的測試來檢驗其對特定健康結果的影響。它們透過提供個人化的互動體驗來強調用戶參與，這些體驗具有即時回饋、進度追蹤和方便用戶使用介面等功能。數位療法旨在補充傳統的醫療保健方法。它們可以與電子健康記錄 (EHR) 整合，連接患者和醫療保健提供者，以實現無縫的護理協調。它們對術後復健、慢性病管理和老年護理非常有用。它們透過提供便利、經濟高效的解決方案來擴大醫療保健的覆蓋範圍。數位療法可以成為傳統治療方法的一種經濟有效的替代方案。

日本數位療法市場的發展趨勢：

目前，對數位療法的需求不斷成長，這是推動日本市場成長的關鍵因素之一。數位療法透過積極的患者參與、持續監測和個人化干預來改善健康結果。此外，關節炎、心血管疾病、糖尿病和骨質疏鬆症等各種慢性疾病的日益普遍，也推動了創新有效治療方法的引進。數位療法能夠提供個人化的遠距干預，有助於減輕日益增加的慢性疾病所帶來的負擔。此外，科技的快速發展，尤其是在人工智慧 (AI) 和機器學習 (ML) 領域，使得數位介入能夠分析大量資料集、制定個人化治療方案，並持續適應患者的個別需求。透過與穿戴式裝置、感測器和其他連網裝置的整合，數位療法進一步增強了其收集即時健康數據的能力，為臨床醫生提供寶貴的資訊，以輔助其做出明智的決策。此外，向基於價值的醫療保健模式和預防性護理的轉變正在加速，推動了數位療法在日本被廣泛採用，成為一種經濟有效的慢性病管理策略。監管機構、患者和醫療服務提供者也日益認知到投資於數位化干預措施的經濟效益，這些措施不僅可以治療慢性疾病，還能預防疾病進展。此外，不斷完善的數位化療法核准和整合指南及框架，也促進了國內市場的成長。

本報告解答的關鍵問題

日本數位療法市場目前發展狀況如何？未來幾年又將如何發展？
新冠疫情對日本數位療法市場產生了哪些影響？
日本數位療法市場按應用領域分類的市場組成是什麼？
日本數位療法市場以最終用途分類的組成是怎樣的？
日本數位療法市場價值鏈的不同階段有哪些？
日本數位療法市場的主要促進因素和挑戰是什麼？
日本數位療法市場的結構是怎麼樣的？主要參與者有哪些？
日本數位療法市場的競爭程度如何？

Japan digital therapeutics market size reached USD 384.8 Million in 2025 . Looking forward, IMARC Group expects the market to reach USD 2,019.2 Million by 2034 , exhibiting a growth rate (CAGR) of 20.23% during 2026-2034 . The growing prevalence of various chronic diseases like arthritis, cardiovascular complications, diabetes, and osteoporosis, rising advancements in artificial intelligence (AI) and machine learning (ML), and increasing establishment of clear guidelines and frameworks represent some of the key factors driving the market.

Access the full market insights report Request Sample

Digital therapeutics are software-based interventions designed to bring about positive health outcomes by modifying patient behavior and providing clinical support. They comprise behavioral therapy apps, which focus on modifying behavior patterns to address mental health conditions, such as stress, anxiety, and depression. They also include chronic disease management platforms, which help patients monitor and manage their conditions through features like medication reminders, activity tracking, and personalized health recommendations. They encompass remote patient monitoring, which involves the use of wearable devices and sensors to monitor the vital signs and health metrics of patients remotely. They rely on scientific evidence and clinical trials to ensure their effectiveness. They often undergo rigorous testing to validate their impact on specific health outcomes. They prioritize user engagement by providing personalized and interactive experiences. They may include features like real-time feedback, progress tracking, and user-friendly interfaces. Digital therapeutics are designed to complement traditional healthcare approaches. They can integrate with electronic health records (EHRs) and connect patients with healthcare providers for seamless coordination of care. They are useful for post-surgery recovery, chronic disease management, and eldercare. They increase access to healthcare by providing convenient and cost-effective solutions. Digital therapeutics can offer a cost-effective alternative to traditional treatments.

JAPAN DIGITAL THERAPEUTICS MARKET TRENDS:

At present, the increasing demand for digital therapeutics as they contribute to better health outcomes by actively involving patients in their care and continuously monitoring and personalized interventions represents one of the crucial factors impelling the growth of the market in Japan. Besides this, the rising prevalence of various chronic diseases like arthritis, cardiovascular complications, diabetes, and osteoporosis is driving the adoption of innovative and effective treatment modalities. Digital therapeutics addresses the increasing burden of chronic illnesses due to its ability to deliver personalized and remote interventions. In addition, the growing advancements in technology, particularly in the realms of artificial intelligence (AI) and machine learning (ML), are empowering digital interventions to analyze vast datasets, personalize treatment plans, and continuously adapt to individual patient needs. The integration of wearables, sensors, and other connected devices further enhances the capability of digital therapeutics to collect real-time health data, providing clinicians with valuable insights for informed decision-making. Apart from this, the increasing shift towards value-based care models and a focus on preventive healthcare is accelerating the adoption of digital therapeutics as a cost-efficient strategy for managing chronic conditions in the country. Regulatory bodies, patients, and healthcare providers are also recognizing the economic benefits of investing in digital interventions that not only treat but also prevent the exacerbation of chronic diseases. Additionally, the rising establishment of clear guidelines and frameworks for digital therapeutics approval and integration into mainstream healthcare is supporting the market growth in the country.

JAPAN DIGITAL THERAPEUTICS MARKET SEGMENTATION:

Application Insights:

To get detailed segment analysis of this market Request Sample
Diabetes
Obesity
CVD
CNS Disease
Respiratory Diseases
Smoking Cessation
Others
Diabetes
Obesity
CVD
CNS Disease
Respiratory Diseases
Smoking Cessation
Others

End Use Insights:

Patients
Providers
Payers
Employers
Others
Patients
Providers
Payers
Employers
Others

Regional Insights:

To get detailed regional analysis of this market Request Sample
Kanto Region
Kansai/Kinki Region
Central/ Chubu Region
Kyushu-Okinawa Region
Tohoku Region
Chugoku Region
Hokkaido Region
Shikoku Region
Kanto Region
Kansai/Kinki Region
Central/ Chubu Region
Kyushu-Okinawa Region
Tohoku Region
Chugoku Region
Hokkaido Region
Shikoku Region
The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

COMPETITIVE LANDSCAPE:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

KEY QUESTIONS ANSWERED IN THIS REPORT
How has the Japan digital therapeutics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan digital therapeutics market?
What is the breakup of the Japan digital therapeutics market on the basis of application?
What is the breakup of the Japan digital therapeutics market on the basis of end use?
What are the various stages in the value chain of the Japan digital therapeutics market?
What are the key driving factors and challenges in the Japan digital therapeutics?
What is the structure of the Japan digital therapeutics market and who are the key players?
What is the degree of competition in the Japan digital therapeutics market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Digital Therapeutics Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Digital Therapeutics Market Landscape

5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)

6 Japan Digital Therapeutics Market - Breakup by Application

6.1 Diabetes
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2020-2025)
- 6.1.3 Market Forecast (2026-2034)
6.2 Obesity
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2020-2025)
- 6.2.3 Market Forecast (2026-2034)
6.3 CVD
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2020-2025)
- 6.3.3 Market Forecast (2026-2034)
6.4 CNS Disease
- 6.4.1 Overview
- 6.4.2 Historical and Current Market Trends (2020-2025)
- 6.4.3 Market Forecast (2026-2034)
6.5 Respiratory Diseases
- 6.5.1 Overview
- 6.5.2 Historical and Current Market Trends (2020-2025)
- 6.5.3 Market Forecast (2026-2034)
6.6 Smoking Cessation
- 6.6.1 Overview
- 6.6.2 Historical and Current Market Trends (2020-2025)
- 6.6.3 Market Forecast (2026-2034)
6.7 Others
- 6.7.1 Historical and Current Market Trends (2020-2025)
- 6.7.2 Market Forecast (2026-2034)

7 Japan Digital Therapeutics Market - Breakup by End Use

7.1 Patients
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2020-2025)
- 7.1.3 Market Forecast (2026-2034)
7.2 Providers
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2020-2025)
- 7.2.3 Market Forecast (2026-2034)
7.3 Payers
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2020-2025)
- 7.3.3 Market Forecast (2026-2034)
7.4 Employers
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2020-2025)
- 7.4.3 Market Forecast (2026-2034)
7.5 Others
- 7.5.1 Historical and Current Market Trends (2020-2025)
- 7.5.2 Market Forecast (2026-2034)

8 Japan Digital Therapeutics Market - Breakup by Region

8.1 Kanto Region
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2020-2025)
- 8.1.3 Market Breakup by Application
- 8.1.4 Market Breakup by End Use
- 8.1.5 Key Players
- 8.1.6 Market Forecast (2026-2034)
8.2 Kansai/Kinki Region
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2020-2025)
- 8.2.3 Market Breakup by Application
- 8.2.4 Market Breakup by End Use
- 8.2.5 Key Players
- 8.2.6 Market Forecast (2026-2034)
8.3 Central/ Chubu Region
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2020-2025)
- 8.3.3 Market Breakup by Application
- 8.3.4 Market Breakup by End Use
- 8.3.5 Key Players
- 8.3.6 Market Forecast (2026-2034)
8.4 Kyushu-Okinawa Region
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2020-2025)
- 8.4.3 Market Breakup by Application
- 8.4.4 Market Breakup by End Use
- 8.4.5 Key Players
- 8.4.6 Market Forecast (2026-2034)
8.5 Tohoku Region
- 8.5.1 Overview
- 8.5.2 Historical and Current Market Trends (2020-2025)
- 8.5.3 Market Breakup by Application
- 8.5.4 Market Breakup by End Use
- 8.5.5 Key Players
- 8.5.6 Market Forecast (2026-2034)
8.6 Chugoku Region
- 8.6.1 Overview
- 8.6.2 Historical and Current Market Trends (2020-2025)
- 8.6.3 Market Breakup by Application
- 8.6.4 Market Breakup by End Use
- 8.6.5 Key Players
- 8.6.6 Market Forecast (2026-2034)
8.7 Hokkaido Region
- 8.7.1 Overview
- 8.7.2 Historical and Current Market Trends (2020-2025)
- 8.7.3 Market Breakup by Application
- 8.7.4 Market Breakup by End Use
- 8.7.5 Key Players
- 8.7.6 Market Forecast (2026-2034)
8.8 Shikoku Region
- 8.8.1 Overview
- 8.8.2 Historical and Current Market Trends (2020-2025)
- 8.8.3 Market Breakup by Application
- 8.8.4 Market Breakup by End Use
- 8.8.5 Key Players
- 8.8.6 Market Forecast (2026-2034)

9 Japan Digital Therapeutics Market - Competitive Landscape

9.1 Overview
9.2 Market Structure
9.3 Market Player Positioning
9.4 Top Winning Strategies
9.5 Competitive Dashboard
9.6 Company Evaluation Quadrant

10 Profiles of Key Players

10.1 Company A
- 10.1.1 Business Overview
- 10.1.2 Product Portfolio
- 10.1.3 Business Strategies
- 10.1.4 SWOT Analysis
- 10.1.5 Major News and Events
10.2 Company B
- 10.2.1 Business Overview
- 10.2.2 Product Portfolio
- 10.2.3 Business Strategies
- 10.2.4 SWOT Analysis
- 10.2.5 Major News and Events
10.3 Company C
- 10.3.1 Business Overview
- 10.3.2 Product Portfolio
- 10.3.3 Business Strategies
- 10.3.4 SWOT Analysis
- 10.3.5 Major News and Events
10.4 Company D
- 10.4.1 Business Overview
- 10.4.2 Product Portfolio
- 10.4.3 Business Strategies
- 10.4.4 SWOT Analysis
- 10.4.5 Major News and Events
10.5 Company E
- 10.5.1 Business Overview
- 10.5.2 Product Portfolio
- 10.5.3 Business Strategies
- 10.5.4 SWOT Analysis
- 10.5.5 Major News and Events

11 Japan Digital Therapeutics Market - Industry Analysis

11.1 Drivers, Restraints, and Opportunities
- 11.1.1 Overview
- 11.1.2 Drivers
- 11.1.3 Restraints
- 11.1.4 Opportunities
11.2 Porters Five Forces Analysis
- 11.2.1 Overview
- 11.2.2 Bargaining Power of Buyers
- 11.2.3 Bargaining Power of Suppliers
- 11.2.4 Degree of Competition
- 11.2.5 Threat of New Entrants
- 11.2.6 Threat of Substitutes
11.3 Value Chain Analysis